Seeing the Future. Expansion - test

December 8, 2022 11 am EST

On-Demand AVAILABLE  "Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond", presented by Dr. Mark Wissel, Director of R&D, Eurofins Viracor Biopharma.

November 11, 2022 11 am EST

On-Demand AVAILABLE "Next-Generation Sequencing Applications for Antiviral Drug Development", presented by Dr. Kirthi Kutambuka, Senior Research Scientist, Eurofins Viracor BioPharma

Check out the latest Eurofins BioPharma Newsletter

Eurofins Viracor is proud to announce our Grand Opening Celebration event on Thursday, October 6th, 2022.

Eurofins Viracor Biopharma credited for role in Moderna COVE Vaccine Clinical Trial.

Check out this new eBook detailing key methods in clinical vaccine development on BioAnalysisZone.com

Check out the latest BioPharma Newsletter

Eurofins Viracor BioPharma is proud to announce that we have opened a state-of-the art, 110,000 sq. ft testing facility, nearly doubling our footprint in 2022.

May 16-19 2022 

We’re excited to meet Gene and Cell Therapy professionals from around the world this week at #ASGCT22! Visit us at Booth #466

February 23, 2022 11 am EST

On-Demand AVAILABLE "Defining Specificity within the ELISpot Assay" Presented by TJ Beadnell, PhD, Scientific Manager, R&D.